Skip to content
lifestyle.microcapnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Deerfield Group
Magnet Biomedicine Expands Leadership with Appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer
January 13, 2026
Averna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
Muna Therapeutics Awarded $1 Million Alzheimer’s Association Grant to Advance Clinical Development of Novel Oral TREM2 Agonist MNA-001 for Alzheimer’s
January 8, 2026
Replicate Bioscience Awarded Grants to Develop New srRNA Vaccines for HIV and Malaria
January 8, 2026
Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
January 7, 2026
Replicate Bioscience Appoints Kathy Fernando, Ph.D., as Chief Business Officer
December 17, 2025
Hemab Therapeutics Announces Positive Complete Phase 2 Data for Sutacimig in Glanzmann Thrombasthenia at ASH 2025; Plans to Advance to Pivotal Phase 3 Study
December 15, 2025
Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study, STARt-002, at the 2025 San Antonio Breast Cancer Symposium
December 13, 2025
K36 Therapeutics announces presentation of First-in-Human Clinical Data for Gintemetostat (KTX-1001) Demonstrating Target Engagement and Clinical Activity in Multiple Myeloma at ASH 2025 and the Appointment of Dr. Shinta Cheng, M.D., Ph.D., as Chief Medical Officer
December 6, 2025
Alpha-9 Oncology Announces First Patient Dosed in Phase 1 Study of A9-3408 for the Treatment of Melanoma
December 5, 2025
←
Previous Page
1
2
3
4
Next Page
→